W. Basher

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

J. Zidan, I. Dashkovsky, C. Stayerman, 2005, British Journal of Cancer.

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease.

J. Zidan, W. Basher, C. Cozacov, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma.

J. Zidan, W. Basher, O. Hussein, 2004, The oncologist.

Pure versus follicular variant of papillary thyroid carcinoma

A. Kuten, J. Zidan, W. Basher, 2003, Cancer.

Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer

Z. Keidar, O. Israel, J. Zidan, 2004, Medical oncology.

Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel

E. Friedman, J. Zidan, W. Basher, 2012, International journal of cancer.

First-line Treatment With Capecitabine Combined With Irinotecan in Patients With Advanced Colorectal Carcinoma: A Phase II Study

N. Assy, J. Zidan, W. Basher, 2012, Journal of clinical gastroenterology.

Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel

J. Zidan, W. Basher, M. Steiner, 2012, International Journal of Cancer.

First-line Treatment With Capecitabine Combined With Irinotecan in Patients With Advanced Colorectal Carcinoma: A Phase II Study

N. Assy, J. Zidan, W. Basher, 2012, Journal of Clinical Gastroenterology.

Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel

J. Zidan, W. Basher, M. Barchana, 2010, Familial Cancer.